Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
133.2 USD | -1.29% |
|
-4.93% | +0.96% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.96% | 13.58B | |
+18.00% | 125B | |
+13.14% | 108B | |
-7.18% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-12.73% | 16.37B | |
+26.45% | 11.66B | |
+86.80% | 9.17B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- JPMorgan Adjusts Price Target on Neurocrine Biosciences to $158 From $148, Maintains Overweight Rating